VELLA, Marco
 Distribuzione geografica
Continente #
NA - Nord America 3.528
EU - Europa 3.465
AS - Asia 539
AF - Africa 25
SA - Sud America 9
Continente sconosciuto - Info sul continente non disponibili 4
OC - Oceania 3
Totale 7.573
Nazione #
US - Stati Uniti d'America 3.515
IT - Italia 2.359
CN - Cina 246
SG - Singapore 208
FI - Finlandia 201
UA - Ucraina 196
DE - Germania 182
IE - Irlanda 105
GB - Regno Unito 99
SE - Svezia 94
FR - Francia 57
RU - Federazione Russa 37
BE - Belgio 31
IN - India 24
RO - Romania 21
CH - Svizzera 18
CI - Costa d'Avorio 17
NL - Olanda 15
TW - Taiwan 12
CA - Canada 9
KR - Corea 9
LB - Libano 7
PL - Polonia 6
PT - Portogallo 6
AT - Austria 5
CZ - Repubblica Ceca 5
ES - Italia 5
HK - Hong Kong 5
PH - Filippine 5
TR - Turchia 5
BR - Brasile 4
EE - Estonia 4
GR - Grecia 4
EU - Europa 3
IR - Iran 3
JP - Giappone 3
SA - Arabia Saudita 3
AU - Australia 2
BA - Bosnia-Erzegovina 2
BG - Bulgaria 2
EC - Ecuador 2
GH - Ghana 2
HR - Croazia 2
MX - Messico 2
NO - Norvegia 2
SI - Slovenia 2
TN - Tunisia 2
UZ - Uzbekistan 2
ZA - Sudafrica 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AR - Argentina 1
BD - Bangladesh 1
CL - Cile 1
DO - Repubblica Dominicana 1
IL - Israele 1
LT - Lituania 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MT - Malta 1
NZ - Nuova Zelanda 1
PA - Panama 1
PK - Pakistan 1
SC - Seychelles 1
TH - Thailandia 1
UY - Uruguay 1
VN - Vietnam 1
Totale 7.573
Città #
Chandler 449
Fairfield 420
Ashburn 289
Woodbridge 275
Wilmington 219
Rome 201
Houston 176
Ann Arbor 173
Milan 163
Singapore 163
Seattle 158
Cambridge 124
Palermo 123
Jacksonville 106
Medford 106
Dublin 103
Des Moines 91
Princeton 65
Nanjing 64
Naples 56
Altamura 52
San Diego 40
Turin 38
Dearborn 37
Lawrence 34
Tulsa 33
Boardman 32
Brussels 31
Beijing 30
Bologna 27
Bari 26
New York 26
Catania 24
Florence 21
Nave 21
Padova 20
Santa Clara 20
London 18
Abidjan 17
Bremen 17
Nanchang 17
Shenyang 17
Helsinki 16
Redwood City 16
Cagliari 15
Falls Church 15
Jiaxing 15
Ludwigshafen am Rhein 15
Venice 14
Napoli 13
Hebei 12
Tianjin 12
Jinan 11
Munich 11
Parma 11
Reggio Emilia 11
Taranto 11
Genoa 10
Kumar 10
Monza 10
Changsha 9
Auburn Hills 8
Dallas 8
Los Angeles 8
Qualiano 8
Seongnam 8
Seveso 8
Verona 8
Brescia 7
Caserta 7
Columbus 7
Modena 7
Ningbo 7
Viareggio 7
Zhengzhou 7
Ascoli Piceno 6
Bergamo 6
Mugnano di Napoli 6
Pune 6
Stockholm 6
Zurich 6
Atlanta 5
Bagnacavallo 5
Cosenza 5
Edinburgh 5
Legnano 5
Ravenna 5
Redmond 5
Rimini 5
Saint Petersburg 5
San Mateo 5
Tavagnacco 5
Andover 4
Battipaglia 4
Binetto 4
Bolzano 4
Casoria 4
Cassino 4
Cernusco sul Naviglio 4
Chicago 4
Totale 4.587
Nome #
Emergenze-urgenze urologiche e dell'apparato genitale maschile 1.753
Characterization of human infiltrating and circulating gamma-delta t cells in prostate cancer 218
Premature ejaculation: Pharmacotherapy vs group psychotherapy alone or in combination 196
Clinical and biochemical markers of visceral adipose tissue activity: Body mass index, visceral adiposity index, leptin, adiponectin, and matrix metalloproteinase-3. Correlation with Gleason patterns 4 and 5 at prostate biopsy 191
Premature Ejaculation: Comparison of treatment. Pharmacotherapy vs Pharmacotherapy in association with group psychotherapy vs group psychotherapy 169
Urethroplasty with dorsal buccal mucosa graft. Is it still the method of choice in long term urethral stenosis? 166
Correlation between GP-170 expression, prognosis, and chemoresistance of superficial bladder carcinoma 157
PATHOPHYSIOLOGY AND CLINICAL ASPECTS OF URINARY LITHIASIS 151
Segmental resection of distal ureter with termino-terminal ureteric anastomosis vs bladder cuff removal and ureteric re-implantation for upper tract urothelial carcinoma: results of a multicentre study 151
Segreto Professionale e diritto alla privacy 149
A phase I-II study on intravesical Gemcitabine in superficial bladder papillary tumors 140
ESWL Prediction of outcome and failure Prevention 140
Carcinoma uroteliale in cisti pielogena 139
An uncommon case of sarcomatoid urothelial carcinoma in covered bladder exstrophy 135
Dall'erba spaccapietre alla medicina ayurvedica. Attualità sulle cosiddette medicine non convenzionali in urologia. 113
Intravesical gemcitabine in superficial bladder tumours preliminary results of a phase I-II study 112
Relation between sexual dysfunctions and epilepsy, type of epilepsy, type of antiepileptic drugs: a prospective study 112
Carcinoma della prostata 110
Segmental ureterectomy vs. radical nephroureterectomy for ureteral carcinoma in patients with a preoperative glomerular filtration rate less than 90 ml/min/1.73 m2: A multicenter study 110
INTRAVESICAL GEMCITABINE IN SUPERFICIAL BLADDER TUMOURS.RESULTS OF A PHASE I-II STUDY 108
FEMALE GENITAL MUTILATIONS: GENITO-URINARY COMPLICATIONS AND ETHICAL-LEGAL ASPECTS 107
Ruolo prognostico della p53 nel tumore vescicale superficiale. Correlazione con recidiva e progressione – 103
Circumcision and Sexually Transmitted Disease Prevention: Evidence and Reticence 101
Diagnostic tools for female urethral diverticulum: Current perspectives 96
Intravesical gemcitabine is superficial bladder tumours. Results of a phase I-II study 94
Does Smoking Cessation at Primary Diagnosis Reduce the Recurrence Risk of Nonmuscle-Invasive Bladder Cancer? Results of a Prospective Study 94
Calcolosi urinaria 91
La p53 nel tumore vescicale superficiale (Ta-T1, G1-3) 90
Traumi del rene, della vescica, delle vie urinarie 90
GRAVE EMORRAGIA RICORRENTE DEL CONDOTTO ILEALE DA IPERTENSIONE PORTALE: PRIMA ESPERIENZA MONDIALE CON SCLEROTIZZAZIONE VASALE ECOGUIDATA. 88
Predictive variables of spontaneous micturition recovery after acute urinary retention in men with benign prostatic enlargement: An observational prospective study 88
GRAVE EMORRAGIA RICORRENTE DEL CONDOTTO ILEALE DA IPERTENSIONE PORTALE: PRIMA ESPERIENZA MONDIALE CON SCLEROTIZZAZIONE VASALE ECOGUIDATA 86
Aspetti Medico-Legali in uro-riabilitazione. Aspetti urologici 86
Ipertermia e chemioterapia nel tumore vescicale superficiale a medio rischio di recidiva:esperienza preliminare 83
Localizzazione S1 di Herpes Zooster: un raro caso di ritenzione urinaria. 82
Penile Enhancement Procedures: Urological And Ethicolegal Issues 81
IS IT POSSIBLE TO PREDICT CHEMORESISTANCE OF SUPERFICIAL BLADDER CARCINOMA? 79
Urodinamica 79
Can we clinically distinguish anejaculation from retrograde ejaculation in patients on α1A-blockers therapy for lower urinary tract symptoms? 78
L'anestesia pericapsulare in corso di biopsia prostatica transrettale sotto guida ecografica 77
Sindromi prostatitiche croniche (SPC), Chronic Pelvic Pain Syndrome e cistite interstiziale. Semplice analogia o unità patogenetica? Risultati di uno studio pilota sul trattamento delle SPC con associazione di un anti-istaminico ed un eparinoide. 76
Ipertermia e chemioterapia nel tumore vescicale superficiale a medio-alto rischio:esperienza preliminare sulla tollerabilità. 75
Eiaculazione precoce: Trattamenti a confronto. Terapia medica vs terapia medica in associazione con Psicoterapia di gruppo vs Psicoterapia di Gruppo - Poster P45 75
PRELIMINARY DATA ON PSA CHANGES DURING INTRAVESICAL THERAPY FOR NON-MUSCLE INVASIVE BLADDER CANCER 70
Ruolo prognostico della p53 nel tumore vescicale superficiale. Correlazione con recidiva e progressione 69
Sildenafil orodispersible film in the treatment of erectile dysfunction after radical prostatectomy: A single-centre open-label uncontrolled trial 69
Smoking cessation and outcome of patients affected by non muscle invasive bladder cancer (NMI-BC) 66
Calcolosi urinaria 66
Vinflunine in Metastatic Urothelial Carcinoma of the Bladder in Progression after a Platinum-Containing Regimen 64
Ruolo dell'ecografia con mezzo di contrasto ecografico nella stadiazione dei tumori vescicali. 63
Spontaneous extrusion of male genital pearling 63
Socio-Demographic Characteristics and Sexual Behavioral Factors of Patients with Sexually Transmitted Infections Attending a Hospital in Southern Italy 62
Potential impact of a nonavalent anti HPV vaccine in Italian men with and without clinical manifestations 60
Prognostic role in common clinical practice of neutrophil-to-lymphocyte ratio in unselected bladder cancer 59
Is Kelami's Method Still Useful in the Smartphone Era? The Virtual 3-Dimensional Reconstruction of Penile Curvature in Patients With Peyronie's Disease: A Pilot Study 58
Intravesical gemcitabine in superficial bladder tumors. Results of a phase I-II study 57
The potential role of COVID-19 hygienic measures in reducing infective complications during hospitalization 57
Violence against women in heterosexual couples: A review of psychological and medico-legal considerations 52
Can we ameliorate the compliance to intravesical bcg maintenance? Analysis of the causes of treatment interruption in 160 consecutive patients. 49
Urodynamics and Overactive Bladder (OAB). What's the incidence of detrusorial overactivity (DO) and What's the role of isometric detrusorial pressure? A prospective stdy. 48
null 47
MP43-14 COMPARISON BETWEEN QUINOLONES AND OTHER ANTIBIOTICS IN PREVENTING INFECTIVE COMPLICATIONS IN TRANSRECTAL PROSTATE BIOPSY 47
Images - Computed tomography urographic appearance of traumatic rupture of renal cyst into the pyelocaliceal system 43
EGFR CELL EXPRESSION IN BLADDER WASHINGS AS A RISK MARKER TOOL IN NON MUSCLE-INVASIVE BLADDER CANCER. PRELIMINARY EXPERIENCE 41
LOWER RESPONSE TO INTRAVESICAL ADJUVANT THERAPY IN HIGH-RISK BLADDER CANCER COULD BE RELATED TO THE UROTHELIAL EXPRESSION OF EGFR 41
Preliminary Results of ERAS Protocol in a Single Surgeon Prospective Case Series 23
Role of hygienic measures against COVID-19 on infective complications after urological interventions 23
Segmental Ureterectomy Versus Radical Nephroureterectomy in Older Patients Treated for Upper Tract Urothelial Carcinoma 21
Quality-of-Life Outcomes in Female Patients With Ileal Conduit or Orthotopic Neobladder Urinary Diversion: 6-Month Results of a Muflticenter Prospective Study 20
Trattamento dell'incontinenza urinaria post-prostatectomia di grado severo mediante l'uso di sling tipo "AdVance" 14
null 9
null 3
Totale 7.883
Categoria #
all - tutte 26.383
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 26.383


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020764 0 0 0 0 106 135 106 73 98 85 104 57
2020/20211.011 42 68 68 87 101 75 92 77 97 60 105 139
2021/20221.003 72 148 65 51 51 44 34 70 103 136 63 166
2022/20231.800 122 202 56 174 163 259 157 156 164 99 154 94
2023/20241.203 106 150 123 149 103 135 102 81 48 60 63 83
2024/2025491 61 103 108 147 72 0 0 0 0 0 0 0
Totale 7.883